Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Gould LH"'
Autor:
Harriman Kh, Long Cm, Brandi Limbago, Havill Nl, Gould Lh, L C McDonald, Jones Tf, Angela Thompson, George Killgore, George E. Hannett, Mickelson S, Sarah L. Lathrop, Frederick J. Angulo, Park Mm
Publikováno v:
Journal of Clinical Microbiology. 47:3004-3007
Clostridium difficile isolates from presumed community-associated infections ( n = 92) were characterized by toxinotyping, pulsed-field gel electrophoresis, tcdC and cdtB PCR, and antimicrobial susceptibility. Nine toxinotypes (TOX) and 31 PFGE patte
Publikováno v:
MMWR. Morbidity and mortality weekly report. 62(54)
Autor:
Silverman Pr, Fishbein Db, Prime Ms, Mitchell T, Gould Lh, Swerdlow Dl, Dee Dl, Kutty Pk, Massoudi M
Publikováno v:
American journal of health behavior. 38(3)
OBJECTIVES To describe student and faculty attitudes towards and adherence to nonpharmaceutical control measures during the first-known university outbreak of 2009 pandemic influenza A (H1N1). METHODS Preferred information sources, control measure ad
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gould LH; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, New York, NY, United States., Fee R; Optum, Eden Prairie, MN, United States., White J; Optum, Eden Prairie, MN, United States., Webb N; Optum, Eden Prairie, MN, United States., Carlyle M; Optum, Eden Prairie, MN, United States., Dick L; Optum, Eden Prairie, MN, United States., Tan Y; Medical Affairs, Evidence Generation Statistics, Pfizer Inc, Cambridge, MA, United States (., Walker V; Optum, Eden Prairie, MN, United States., Angulo FJ; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, New York, NY, United States., Moïsi JC; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, Paris, France., Stark JH; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, Cambridge, MA, United States., Pugh S; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, New York, NY, United States.
Publikováno v:
American journal of epidemiology [Am J Epidemiol] 2024 Sep 20. Date of Electronic Publication: 2024 Sep 20.
Autor:
Angulo FJ; Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Collegeville, PA, USA. Electronic address: frederick.angulo@pfizer.com., Colby E; Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Collegeville, PA, USA., Lebech AM; Department of Infectious Diseases, University Hospital Copenhagen-Rigshospitalet, Copenhagen, Denmark., Lindgren PE; Division of Inflammation and Infection, Linköping University, Linköping, Sweden; Department of Laboratory Medicine, Division of Clinical Microbiology, Ryhov County Hospital, Jönköping, Sweden., Moniuszko-Malinowska A; Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Bialystok, Poland., Strle F; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Olsen J; Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Collegeville, PA, USA., Brestrich G; Vaccines and Antivirals Medical Affairs, Pfizer Pharma GmbH, Berlin, Germany., Vyse A; Vaccines and Antivirals Medical Affairs, Tadworth, Surrey, UK., Shafquat M; Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, New York, NY, USA., Gould LH; Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, New York, NY, USA., Kelly PH; Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Collegeville, PA, USA., Pilz A; Vaccines and Antivirals Medical Affairs, Pfizer Corporation Austria, Vienna, Austria., Halsby K; Vaccines and Antivirals Medical Affairs, Tadworth, Surrey, UK., Moïsi JC; Vaccines and Antivirals Medical Affairs, Paris, France., Stark JH; Pfizer US Commercial Division, Vaccines and Antivirals Medical Affairs, Cambridge, MA, USA.
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Sep 20; Vol. 149, pp. 107242. Date of Electronic Publication: 2024 Sep 20.
Autor:
Gould LH; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, New York, New York, USA., Stark JH; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, Cambridge, Massachusetts, USA., McFadden B; Behavioralize LLC, Wynnewood, Pennsylvania, USA.; The Department of Agricultural Economics and Agribusiness, University of Arkansas, Fayetteville, Arkansas, USA., Patel N; Behavioralize LLC, Wynnewood, Pennsylvania, USA., Kelly PH; Global Medical Affairs, Vaccines and Antivirals, Pfizer US Commercial Division, Collegeville, Pennsylvania, USA., Riis J; Behavioralize LLC, Wynnewood, Pennsylvania, USA.
Publikováno v:
Zoonoses and public health [Zoonoses Public Health] 2024 Aug; Vol. 71 (5), pp. 526-537. Date of Electronic Publication: 2024 May 10.
Autor:
Gould LH; Global Medical Affairs, Vaccines and Antivirals, Pfizer Biopharma Group, New York, New York, USA., Fathalla A; Global Medical Affairs, Vaccines and Antivirals, Pfizer Biopharma Group, New York, New York, USA., Moïsi JC; Global Vaccines and Antivirals, Pfizer Biopharma Group, Paris, France., Stark JH; Global Vaccines and Antivirals, Pfizer Biopharma Group, Cambridge, Massachusetts, USA.
Publikováno v:
Zoonoses and public health [Zoonoses Public Health] 2024 Aug; Vol. 71 (5), pp. 469-479. Date of Electronic Publication: 2024 Apr 24.